Clinical Trial Central Laboratory Services Market
完整報告名稱與涵蓋範圍
Clinical Trial Central Laboratory Services Market Size, Share & Trends Analysis Report By Services (Biomarker Testing Services, Sample Collection and Processing, Microbiology Services, Anatomic Pathology/Histology, Genomic and Molecular Testing, Pharmacokinetics/Pharmacodynamics (PK/PD), Logistics & Sample Management, Data Management & Reporting), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, Neurology, Infectious Diseases, Immunology & Autoimmune Diseases), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations), By Region, And By Segment Forecasts, 2025-2034.
報告摘要
The worldwide Clinical Trial Central Laboratory Services Market stood at USD 4.1 billion in 2024, and is forecasted to reach USD 11.0 billion by 2034, recording a CAGR of 10.7% from 2025 through 2034.
Clinical Trial Central Laboratory Services encompasses specialized laboratory services that support clinical trials by providing centralized and uniform testing, analysis, and data management. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is fueled by mounting need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Trial Central Laboratory Services Market Snapshot
Chapter 4. Global Clinical Trial Central Laboratory Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Clinical Trial Central Laboratory Services Market Industry Trends
4.10. Global Clinical Trial Central Laboratory Services Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Clinical Trial Central Laboratory Services Market Segmentation 1: By Services, Estimates & Trend Analysis
5.1. Market Share by Services, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Services:
5.2.1. Biomarker Testing Services
5.2.2. Microbiology Services
5.2.3. Anatomic Pathology/Histology
5.2.4. Pharmacokinetics/Pharmacodynamics (PK/PD)
5.2.5. Genomic and Molecular Testing
5.2.6. Sample Collection and Processing
5.2.7. Logistics & Sample Management
5.2.8. Data Management & Reporting
5.2.9. Others
Chapter 6. Clinical Trial Central Laboratory Services Market Segmentation 2: By Phase, Estimates & Trend Analysis
6.1. Market Share by Phase, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Phase:
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
Chapter 7. Clinical Trial Central Laboratory Services Market Segmentation 3: By Indication, Estimates & Trend Analysis
7.1. Market Share by Indication, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Indication:
7.2.1. Oncology
7.2.2. Cardiology
7.2.3. Neurology
7.2.4. Infectious Diseases
7.2.5. Immunology & Autoimmune Diseases
7.2.6. Others
Chapter 8. Clinical Trial Central Laboratory Services Market Segmentation 4: By End-use, Estimates & Trend Analysis
8.1. Market Share by End-use, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-use:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Contract Research Organizations
8.2.3. Others
Chapter 9. Clinical Trial Central Laboratory Services Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Clinical Trial Central Laboratory Services Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Services, 2021-2034
9.2.3. North America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
9.2.4. North America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.2.5. North America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
9.3. Europe
9.3.1. Europe Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Services, 2021-2034
9.3.3. Europe Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
9.3.4. Europe Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.3.5. Europe Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Services, 2021-2034
9.4.3. Asia Pacific Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
9.4.4. Asia Pacific Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.4.5. Asia Pacific Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
9.5. Latin America
9.5.1. Latin America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Services, 2021-2034
9.5.3. Latin America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
9.5.4. Latin America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.5.5. Latin America Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Services, 2021-2034
9.6.3. Middle East & Africa Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
9.6.4. Middle East & Africa Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.6.5. Middle East & Africa Clinical Trial Central Laboratory Services Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Labcorp
10.2.1.1. Business Overview
10.2.1.2. Key Services/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. ICON plc
10.2.3. Eurofins Scientific
10.2.4. Thermo Fisher Scientific Inc.
10.2.5. Medpace
10.2.6. Q² Solutions
10.2.7. Syneos Health
10.2.8. Charles River Laboratories
10.2.9. SGS
10.2.10. LabConnect
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們